日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Acceptability of Tele-Critical Care Consultation for Patients at Risk of ICU Admission

远程重症监护会诊对有入住ICU风险患者的可接受性

Fritz, Bradley A; Palmer, Christopher; Arammash, Hosam; Konzen, Lisa; White, Jason; Bertrand, Jill; Simpson, Terah; Alagna, Rebecca; Kerby, Paul; Buckman, Sara A; Despotovic, Vladimir; Martin, Nelda K; Drewry, Anne M; Abraham, Joanna

Bridging to orthotopic heart transplant: Reducing the risk of intra-operative blood loss

过渡到原位心脏移植:降低术中出血风险

Miller, Phoebe; Akcelik, Andrew; Murillo, Alyssa; Baskin, Alison; Merriman, Alexander; Arammash, Mohammad; Kiran, Shreyas; Smith, Jason; Fiedler, Amy G

Minimally invasive aortic valve replacement with Y-incision aortic root enlargement

微创主动脉瓣置换术联合Y形切口主动脉根部扩大术

Boskovski, Marko T; Arammash, Mohammad; Nguyen, Tom C; Tseng, Elaine E

Use of ICG dye for urinary tract identification during robotic peritoneal window creation for a post-kidney transplant lymphocele

在肾移植术后淋巴囊肿的机器人辅助腹膜开窗术中,使用吲哚菁绿(ICG)染料进行泌尿道识别

Arammash, Mohammad; Arammash, Hosam; Syed, Shareef

YIV-818-A: a novel therapeutic agent in prostate cancer management through androgen receptor downregulation, glucocorticoid receptor inhibition, epigenetic regulation, and enhancement of apalutamide, darolutamide, and enzalutamide efficacy

YIV-818-A:一种新型前列腺癌治疗药物,其作用机制包括下调雄激素受体、抑制糖皮质激素受体、表观遗传调控以及增强阿帕鲁胺、达罗鲁胺和恩扎鲁胺的疗效。

Lam, Wing; Arammash, Mohammad; Cai, Wei; Guan, Fulan; Jiang, Zaoli; Liu, Shwu-Huey; Cheng, Peikwen; Cheng, Yung-Chi